Literature DB >> 11431302

Regular review: Managing testicular cancer.

D Dearnaley1, R Huddart, A Horwich.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11431302      PMCID： PMC1120626          DOI： 10.1136/bmj.322.7302.1583

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  27 in total

1.  Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours.

Authors:  E A Rapley; G P Crockford; D Teare; P Biggs; S Seal; R Barfoot; S Edwards; R Hamoudi; K Heimdal; S D Fossâ; K Tucker; J Donald; F Collins; M Friedlander; D Hogg; P Goss; A Heidenreich; W Ormiston; P A Daly; D Forman; T D Oliver; M Leahy; R Huddart; C S Cooper; J G Bodmer; D F Easton; M R Stratton; D T Bishop
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

2.  Public awareness of testicular cancer and the value of self examination.

Authors:  J A Thornhill; R M Conroy; D G Kelly; A Walsh; J J Fennelly; J M Fitzpatrick
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

3.  Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.

Authors:  H Patterson; A R Norman; S S Mitra; J Nicholls; C Fisher; D P Dearnaley; A Horwich; M D Mason; R A Huddart
Journal:  Radiother Oncol       Date:  2001-04       Impact factor: 6.280

4.  Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.

Authors:  R de Wit; J T Roberts; P M Wilkinson; P H de Mulder; G M Mead; S D Fosså; P Cook; L de Prijck; S Stenning; L Collette
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

5.  Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.

Authors:  G Read; S P Stenning; M H Cullen; M C Parkinson; A Horwich; S B Kaye; P A Cook
Journal:  J Clin Oncol       Date:  1992-11       Impact factor: 44.544

6.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

7.  A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.

Authors:  A Horwich; R T Oliver; P M Wilkinson; G M Mead; S J Harland; M H Cullen; J T Roberts; S D Fossa; D P Dearnaley; E Lallemand; S P Stenning
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

8.  Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults.

Authors:  B Summersgill; P Osin; Y J Lu; R Huddart; J Shipley
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

9.  Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.

Authors:  S F Hain; M J O'Doherty; A R Timothy; M D Leslie; P G Harper; R A Huddart
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

10.  The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).

Authors:  M J Peckham; A Barrett; K H Liew; A Horwich; B Robinson; H J Dobbs; T J McElwain; W F Hendry
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640
View more
  31 in total

1.  Testosterone Level in Testicular Cancer Patients after Chemotherapy.

Authors:  M Sarfraz; Y Ashraf; S Sajid; M A Ashraf
Journal:  West Indian Med J       Date:  2016-04-29       Impact factor: 0.171

2.  The role of meaning in the prediction of psychosocial well-being of testicular cancer survivors.

Authors:  J Fleer; H J Hoekstra; D Th Sleijfer; M A Tuinman; J E H M Hoekstra-Weebers
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

3.  Retroperitoneal lymph node dissection for metastatic germ cell tumours.

Authors:  N Haldipur; S Devaraj; A Shehata; A K Lewis; M O Smith; M Hatton; A Nassef; J D Beard
Journal:  Ann R Coll Surg Engl       Date:  2011-05       Impact factor: 1.891

4.  Scrotal recurrence of germ cell tumour in a non-violated scrotum.

Authors:  Jenny Li; Nicholas Power
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

5.  Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events.

Authors:  J Fleer; H J Hoekstra; D T Sleijfer; M A Tuinman; E C Klip; J E H M Hoekstra-Weebers
Journal:  Support Care Cancer       Date:  2005-09-17       Impact factor: 3.603

Review 6.  [Aftercare in testicular cancer is worthwhile. Recurrences are curable].

Authors:  T S Pottek; K-P Dieckmann
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

Review 7.  Testicular cancer: germ cell tumours.

Authors:  Peter Chung; Padraig Warde
Journal:  BMJ Clin Evid       Date:  2016-01-07

Review 8.  Testicular cancer: seminoma.

Authors:  Richard David Neal; Nicholas Stuart; Clare Wilkinson
Journal:  BMJ Clin Evid       Date:  2007-02-01

9.  Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.

Authors:  Marianne Brydøy; Jan Oldenburg; Olbjørn Klepp; Roy M Bremnes; Erik A Wist; Tore Wentzel-Larsen; Erik R Hauge; Olav Dahl; Sophie D Fosså
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 13.506

10.  Clinical and genetic aspects of testicular germ cell tumours.

Authors:  Martijn F Lutke Holzik; Rolf H Sijmons; Josette Ehm Hoekstra-Weebers; Dirk T Sleijfer; Harald J Hoekstra
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.